Kathleen Brady
Associate Director of Quality Assurance Imaginab
Kathleen has 15+ years combined experience in the pharmaceutical and radiopharmaceutical industries. She has direct hands-on experience in Quality, Regulatory, CMC, Project Management, CDMO Management, Global Supply Chain, and Logistics in both clinical and commercial space. She currently serves on the USP Expert Committee for Small Molecules, where she helps set quality standards for traditional drugs and radiopharmaceuticals.
Thursday 17th September 2026
Rethinking the Build vs Buy Model in Radiopharmaceutical Manufacturing
11:15 am
This session will feature an expert-delivered presentation, before opening to a facilitated audience discussion
- Comparing in-house manufacturing vs CDMO reliance in the context of radiopharmaceutical complexity
- Exploring strategies for combining internal capabilities with strategic CDMO partnerships to ensure continuity of supply while maintaining flexibility
- Evaluating how facility decisions impact control, flexibility, and scalability across the supply chain
- Identifying hidden constraints beyond infrastructure, particularly workforce availability and expertise
